These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4874428)

  • 21. The use and abuse of vasodilator drugs.
    Rose SS
    Vasc Dis; 1967 Apr; 4(2):67-82. PubMed ID: 6027150
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of vascular diseases with Mydocalm.
    Sztankay C
    Ther Hung; 1970; 18(3):121-4. PubMed ID: 5496813
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ
    Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
    [No Abstract]   [Full Text] [Related]  

  • 25. Vascular diseases: new results with pentoxifylline.
    Belcaro G; Cesarone MR; Ippolito E
    Angiology; 2002; 53 Suppl 1():1 p following TOC. PubMed ID: 11863316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vasodilators. Clinical effect in peripheral vascular disorders. A survey of the literature].
    Hallén LG
    Lakartidningen; 1965 Sep; 62(39):3149-52. PubMed ID: 5330352
    [No Abstract]   [Full Text] [Related]  

  • 27. [Can the Doppler method indicate the usefulness of vasodilator therapy?].
    Bartolo M; Antignani PL
    Recenti Prog Med; 1981 Aug; 71(2):175-84. PubMed ID: 7313287
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular insufficiency and Heberden's nodes. A possible etiologic factor.
    Hunter W
    J S C Med Assoc; 1967 May; 63(5):165-9. PubMed ID: 5233029
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of peripheral vascular disorders with dilatol].
    Knapik Z; Twardzicki J; Wlodarczykowa J
    Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
    Chiti E
    Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
    Simões Neto E
    Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of vasoactive agents in clinical practice].
    Coget JM
    Phlebologie; 1990; 43(4):707-13. PubMed ID: 2093930
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic control of the path of the blood flow of the end organs].
    Gersmeyer EF; Leicht E
    Med Welt; 1967 Feb; 8():426-31. PubMed ID: 6044562
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of MD 1035 in peripheral vascular manifestations].
    Barraine R; Efthymiou TP; Marcantoni JP
    Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lysis of mechanically produced spasms of small arteries through local drug administration].
    Klos I
    Z Exp Chir; 1971; 4(5):262-6. PubMed ID: 5162960
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Peripheral vasodilators.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1975 Dec; 32(12):1231-2. PubMed ID: 1211395
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of venous disorders in women].
    Delacroix P
    Sem Hop; 1980 Oct 18-25; 56(39-40):1599-601. PubMed ID: 6255576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.